LEUKOCARE has been granted both ISO 9001 and ISO 13485 certification
In order to achieve ISO standards, LEUKOCARE implemented a QMS for its operations to ensure consistent and high quality of the company’s development processes. KEMA Quality B.V. audited LEUKOCARE for the design, development, manufacturing and distribution of technologies and products for biofunctional surface engineering and stabilisation of biomolecules in the field of medical devices, diagnostics, research products and biopharmaceuticals.
“By achieving ISO certification, LEUKOCARE can now offer full quality assurance in terms of development and implementation of our postcoating technology”, stated Michael Scholl, CEO of LEUKOCARE. “We are developing our technology for additional product ranges and this requires us to operate only on the highest standards of international quality.”
Other news from the department politics & laws
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.